Current Neuro-Oncology

Volume 4 Number 3
31 March 2002

Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 3, 31 March

Didenko VV, Ngo HN, Minchew C, Baskin DS.
Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism.
J Neurosurg. 2002 Mar;96(3):580-4. doi: 10.3171/jns.2002.96.3.0580. PMID: 11883844. Observational study.

Peters TR, Jennings MT, Crowe JE Jr.
Pneumocystis carinii pneumonia in a girl with a midbrain glioma.
Pediatr Hematol Oncol. 2002 Mar;19(2):141-3. doi: 10.1080/08880010252825731. PMID: 11881789. Case report.

Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, Yung WK, Levin VA.
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.
J Clin Oncol. 2002 Mar 1;20(5):1383-8. doi: 10.1200/JCO.2002.20.5.1383. PMID: 11870183. Interventional study.

Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, Herndon JE 2nd, Cokgor I, McLendon RE, Pegram CN, Provenzale JM, Quinn JA, Rich JN, Regalado LV, Sampson JH, Shafman TD, Wikstrand CJ, Wong TZ, Zhao XG, Zalutsky MR, Bigner DD.
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
J Clin Oncol. 2002 Mar 1;20(5):1389-97
. doi: 10.1200/JCO.2002.20.5.1389. PMID: 11870184. Interventional study. ˍ


Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S.
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
J Clin Oncol. 2002 Mar 1;20(5):1375-82
. doi: 10.1200/JCO.2002.20.5.1375. PMID: 11870182. Interventional study. ˍ

Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, Gebarski SS, Sandler HM.
Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.
J Clin Oncol. 2002 Mar 15;20(6):1635-42. doi: 10.1200/JCO.2002.20.6.1635. PMID: 11896114. Observational study.

Raymond E, Campone M, Stupp R, Menten J, Chollet P, Lesimple T, Fety-Deporte R, Lacombe D, Paoletti X, Fumoleau P; EORTC Early Clinical Studies Group (ECSG); Brain Tumor Studies Group (BTSG); New Drug Development Program (NDDP).
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme.
Eur J Cancer. 2002 Mar 15;38(10):1348-50. doi: 10.1016/s0959-8049(02)00070-9. PMID: 12091065. Interventional study. ˍ

Voges J, Weber F, Reszka R, Sturm V, Jacobs A, Heiss WD, Wiestler O, Kapp JF.
Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme.
Hum Gene Ther. 2002 Mar 20;13(5):675-85. doi: 10.1089/10430340252837260. PMID: 11916490. Interventional study protocol. ˍ

Chhieng DC, Elgert P, Cohen JM, Jhala NC, Cangiarella JF.
Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens.
Diagn Cytopathol. 2002 Mar 28;26(4):209-12. doi: 10.1002/dc.10013. PMID: 11933264. Observational study.

Mesiwala AH, Loeser JD.
Visual pathway glioma.
Pediatr Neurosurg. 2002 Mar 28;36(3):161. doi: 10.1159/000048373. PMID: 11919452. Case report.

Bradbury J.
Brain tumour-JC virus link strengthened but not proven.
Lancet Infect Dis. 2002 Mar 31;2(4):201. doi: 10.1016/s1473-3099(02)00255-4. PMID: 11937413. Editorial perspective.